The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Cholinergic signaling in the hippocampus regulates social stress resilience and anxiety- and depression-like behavior
Open accessAbstract
Symptoms of depression can be induced in humans through blockade of acetylcholinesterase (AChE) whereas antidepressant-like effects can be produced in animal models and some clinical trials by limiting activity of acetylcholine (ACh) receptors. Thus, ACh signaling could contribute to the etiology of mood regulation. To test this hypothesis, we administered the AChE inhibitor physostigmine to mice and demonstrated an increase in anxiety- and depression-like behaviors that was reversed by administration of nicotinic or muscarinic antagonists. The behavioral effects of physostigmine were also reversed by administration of the selective serotonin reuptake inhibitor fluoxetine. Administration of fluoxetine also increased AChE activity throughout the brain, with the greatest change in the hippocampus. To determine whether cholinergic signaling in the hippocampus could contribute to the systemic effects of cholinergic drugs, we infused physostigmine or virally delivered shRNAs targeting AChE into the hippocampus. Both pharmacological and molecular genetic decreases in hippocampal AChE activity increased anxiety- and depression-like behaviors and decreased resilience to repeated stress in a social defeat paradigm. The behavioral changes due to shRNA-mediated knockdown of AChE were rescued by coinfusion of an shRNA-resistant AChE transgene into the hippocampus and reversed by systemic administration of fluoxetine. These data demonstrate that ACh signaling in the hippocampus promotes behaviors related to anxiety and depression. The sensitivity of these effects to fluoxetine suggests that shRNA-mediated knockdown of hippocampal AChE represents a model for anxiety- and depression-like phenotypes. Furthermore, abnormalities in the cholinergic system may be critical for the etiology of mood disorders and could represent an endophenotype of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Increasing acetylcholine signaling in the hippocampus via local knockdown of acetylcholine esterase (AChE) results in increased avoidance of anxiogenic environments, in-creased immobility in response to inescapable stress, and decreased threshold for social defeat (Mineur et al. 2013).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Mineur et al. 2013
In the citing paper
“while increased ACh transmission can increase behaviors related to depression in humans (Risch et al., 1980) and rodents (Mineur et al., 2013), the type of circuits/cell types that are modulated by ACh or nAChRs can have opposite effects on mood regulation, and the outcome on behavior depends on the sum of these effects.”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Mineur et al., 2013
In the citing paper
“These results indicate that abnormal nicotinic signaling may underlie depression symptoms (Mineur et al., 2013; Tizabi et al., 2000)”
From Mood and anxiety regulation by nicotinic acetylcholine receptors: A potential pathway to modulate aggression and related behavioral states (2015) · cites this paper as Mineur et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
A "DIRECT-COLORING" THIOCHOLINE METHOD FOR CHOLINESTERASES
Karnovsky, M. J., & ROOTS, L. (1964) · Journal of Histochemistry & Cytochemistry · doi:10.1177/12.3.219 · Cited by 3,368
Krishnan, V., Han, M.-H., Graham, D. L., Berton, O., Renthal, W., Russo, S. J., LaPlant, Q., Graham, A., Lutter, M., Lagace, D. C., et al. (2007) · Cell · doi:10.1016/j.cell.2007.09.018 · Cited by 2,307 · cited 1×
“To test whether manipulations of AChE could potentiate an animal’s susceptibility to psychosocial stress induced by repeated defeat, we also used the submaximal defeat paradigm as reported previously (43).”
MethodEssential role of BDNF in the mesolimbic dopamine pathway in social defeat stress
Berton, O., McClung, C. A., DiLeone, R. J., Krishnan, V., Renthal, W., Russo, S. J., Graham, D., Tsankova, N. M., Bolanos, C. A., Rios, M., et al. (2006) · Science · doi:10.1126/science.1120972 · Cited by 2,129
Cryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Acetylcholinesterase — new roles for an old actor
Soreq, H., & Seidman, S. (2001) · Nature reviews. Neuroscience · doi:10.1038/35067589 · Cited by 1,437
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404
Self-citationA cholinergic-adrenergic hypothesis of mania and depression
Janowsky, D., Davis, J., El-Yousef, M. K., & Sekerke, H. J. (1972) · The Lancet · doi:10.1016/s0140-6736(72)93021-8 · Cited by 1,134
Linking Molecules to Mood: New Insight Into the Biology of Depression
Krishnan, V., & Nestler, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.10030434 · Cited by 666
Acute stress facilitates long-lasting changes in cholinergic gene expression
Kaufer, D., Friedman, A., Seidman, S., & Soreq, H. (1998) · Nature · doi:10.1038/30741 · Cited by 588
Research works printed but not linked: 1
- 10.1037/0735-7044.112.2.352 · DOI
Cited by
Sorted by citations
Items 301–374 of 374
Wang, X.-L., & Serchov, T. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106700 · Cited by 2
Altered basal forebrain regulation of intrinsic brain networks in depressive and anxiety disorders
Jamieson, A. J., Steward, T., Davey, C. G., Ince, S., Agathos, J. A., Moffat, B. A., Glarin, R. K., Felmingham, K. L., & Harrison, B. J. (2025) · Nature Mental Health · doi:10.1038/s44220-025-00496-2 · Cited by 2
Acetylcholinesterase and Association 1 of ACHE 3’ UTR SNP rs17228602 with Psychiatric Disorders
Rumman, B., Habib, R., Awan, S., Javeres, M. N. L., Khan, K., Sadia, K., Tekes, K., & Nurulain, S. M. (2022) · Kuwait Journal of Science · doi:10.48129/kjs.12465 · Cited by 2
Cholinergic Protection in Ischemic Brain Injury
Uteshev, V. V. (2017) · Springer series in translational stroke research · doi:10.1007/978-3-319-45345-3_17 · Cited by 2
Jarcho, M. R., Avery, M. R., Kornacker, K. B., Hollingshead, D., & Lo, D. Y. (2018) · Psi Chi Journal of Psychological Research · doi:10.24839/2325-7342.jn23.5.376 · Cited by 2
Zhou, J. C., Jiang, J.-B., Guo, H., Yang, S. R., Liu, C., Qu, W., Huang, Z. L., & Ding, F. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109217 · Cited by 2
Moshitzky, G., Shoham, S., Madrer, N., Husain, M. A., Greenberg, D., Yirmiya, R., Ben‐Shaul, Y., & Soreq, H. (2020) · Biomolecules · doi:10.3390/biom10060848 · Cited by 2
General Anesthesia and Autonomic Nervous System: Control and Management in Neurosurgery
Savvina, I. A., Petrova, A. O., & Zabrodskaya, Y. M. (2022) · Physiology · doi:10.5772/intechopen.101829 · Cited by 2
Cholinergic Interneurons as a Novel Target of CRF in the Striatum that is Spared by Repeated StressPreprint
Lemos, J. C., Shin, J. H., Ingebretson, A. E., Dobbs, L. K., & Alvarez, V. A. (2018) · SSRN Electronic Journal · doi:10.2139/ssrn.3280248 · Cited by 2
Wang, Y., Haghpanah, F. S., Aw, N., Laine, A. F., & Posner, J. E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.22.110619 · Cited by 2
Bao, K. H. (2021) · Research Square · doi:10.21203/rs.3.rs-374465/v1 · Cited by 2
Wolugbom, J. A., Areloegbe, S. E. J., & Olaniyi, K. S. (2022) · Research Square · doi:10.21203/rs.3.rs-1595335/v1 · Cited by 2
Cryo-EM ligand building using generative AI and molecular dynamicsPreprint
Haloi, N., Howard, R. J., & Lindahl, E. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.10.637508 · Cited by 2
Öz, M., Atalık, K. E. N., & Aslanlar, D. A. (2023) · Kastamonu Medical Journal · doi:10.51271/kmj-0088 · Cited by 1
Al-Habash, I. H., Alshaeb, A., Srpanova, V. B., Alempijevic, D. M., Marković, M. K., Concato, M., Radaelli, D., & D’Errico, S. (2025) · Current Neuropharmacology · doi:10.2174/011570159x344453241129073214 · Cited by 1
Milewski, T. M., Lee, W., Rada, K. R., & Curley, J. P. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70295 · Cited by 2
Wong, T. H. H., Chow, L. H., Wu, Z., Hui, T. K. L., & Tsang, L. M. (2026) · BMC Genomics · doi:10.1186/s12864-026-12899-1 · Cited by 1
Nicotinic Receptors and Mental Illness
Leonard, S. S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1167-7_20 · Cited by 1
Induction of reversible bidirectional social approach bias by olfactory conditioning in male mice
Chan, J., Stout, D., Pittenger, S. T., Picciotto, M. R., & Lewis, A. S. (2019) · Social Neuroscience · doi:10.1080/17470919.2019.1644370 · Cited by 1
Self-citationCHOLINERGIC SYSTEM RESPONSE TO STRESS AND DEPRESSION
Gainutdinov, M. K., Khakimova, D. M., Калинникова, Т. Б., & Shagidullin, R. R. (2019) · Ulyanovsk Medico-biological Journal · doi:10.34014/2227-1848-2019-1-93-102 · Cited by 1
Process of Economic Sanctions Success or Failure
Aghanouri, R., & Sahraii, H. (2022) · Biomedical and Biotechnology Research Journal (BBRJ) · doi:10.4103/bbrj.bbrj_265_22 · Cited by 1
Drug contraindications in comorbid diseases: a protein interactome perspective
Karunakaran, K. B., Ganapathiraju, M. K., Jain, S., Brahmachari, S. K., & Balakrishnan, N. (2024) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-023-00440-3 · Cited by 1
Molecular characterization of the stress network in the human brainPreprint
Meijer, M., Keo, A., van Leeuwen, J. M. C., Dzyubachyk, O., Meijer, O. C., Vinkers, C. H., & Mahfouz, A. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/661587 · Cited by 1
Tolle, H. M., Luppi, A. I., Lawn, T., Roseman, L., Nutt, D., Carhart-Harris, R. L., & Mediano, P. A. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.02.662710 · Cited by 1
Huang, F., Baset, A., & Bello, S. T. (2025) · eLife · doi:10.7554/elife.109001 · Cited by 1
THE IDENTIFICATION OF NOVEL SUSCEPTIBILITY GENES INVOLVED IN ANXIETY DISORDERS
McGregor, N. W. (2013) · SUNScholar (Stellenbosch University) · doi:10.13140/2.1.2731.4569
Development of Antidepressant Drugs Through Targeting α4β2-Nicotinic Acetylcholine Receptors
Zhang, H., Gunosewoyo, H., Fan, Y., Tang, J., & Yu, L.-F. (2016) · Neuromethods · doi:10.1007/978-1-4939-3768-4_11
Mishra, N., & Soreq, H. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802175-0.00012-7
Schoeman, J. C. (2015) · Boloka Institutional Repository (North-west University)
The Neuroendocrine and Neurodevelopmental Effects of Endocrine Disrupting Chemicals
Yirün, A., Erkekoğlu, P., & GÜMÜŞEL, B. K. (2018) · Turkiye Klinikleri Journal of Neurology · doi:10.5336/neuro.2018-59861
Patil, S., & Inamdar, L. S. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11i5.24736
Too much of a good thing? Lecithin and mental health
Tsoukalas, I. (2019) · World Nutrition · doi:10.26596/wn.201910154-62
Moreland-Capuia, A. R. (2019) · Springer eBooks · doi:10.1007/978-3-030-19208-2_6
Positive Effect of Chaiqin Wendan Decoction on Anxiety and Depression Model Rats
Li, X., Li, X., Cai, R., Qi, B., Li, Y., Wang, T., Liu, W., Chen, W., Chen, Y., Ma, M., et al. (2020) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/730/1/012036
Shahidi, ., Dindar, A., Komaki, A., & Sadeghian, R. (2021) · Research Square · doi:10.21203/rs.3.rs-422248/v1
Activation of Caenorhabditis elegans cholinergic system by food deprivation and octopamine
Егорова, А. В., Gatiyatullina, A., Khakimova, D. M., Shagidullin, R. R., & Калинникова, Т. Б. (2022) · AIP conference proceedings · doi:10.1063/5.0092474
Akinduko, A., Salawu, S. O., Akinmoladun, A. C., Akindahunsi, A. A., & Osemwegie, O. O. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4639314
Nemati, S., Edalatmanesh, M. A., & Forouanfar, M. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4970508
Nguyen, T. M., Nguyen, N. P., Nguyen, N. T. Q., Nguyen, N. P. N., Nguyen, L. M. H., Nguyen, T. B., & Nhu, H. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e145293
Nollet, M., Ba, W., Soto, B. A., Yin, C., Lignos, L., Jović, K., Wong, S., Vyssotski, A. L., Yustos, R., Franks, N. P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.09.663930
Huang, F., Baset, A., & Bello, S. T. (2026) · eLife · doi:10.7554/elife.109001.3
Hernández-Abrego, A., Vázquez-Gómez, E., Mejía-Piedras, J., & García‐Colunga, J. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110736
Altered acetylcholine modulations and corticoaccumbal pathway in P11-linked social dysfunction
Dautan, D., Camargo, A., Branzell, N., Brioschi, V. I., Doyon, D., Covatta, E., Marongiu, R., Kaplitt, M. G., Chergui, K., Zhang, X., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03324-2
Doyle, S., Doran, M. M., Cunningham, C. M., & Lowry, J. P. (2025) · European Journal of Neuroscience · doi:10.1111/ejn.70291
Martins, C. C., dos Reis, A. S., da Motta, K. P., da Rocha, V. M. E., Jeske, L. D., Alves, D., Luchese, C., & Wilhelm, E. A. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01674-y
Excitatory cholecystokinin neurons in CA3 area regulate the navigation learning and neuroplasticityPreprint
Huang, F., Baset, A., & Bello, S. T. (2025) · eLife · doi:10.7554/elife.109001.1
Selected Lipidome Components and Their Association with Perinatal Depression
Ładno, D., Nowak, B., Palka, A., Strzelecki, D., & Gawlik-Kotelnicka, O. (2025) · Nutrients · doi:10.3390/nu17223590
van Enkhuizen, J. (2014) · Utrecht University Repository (Utrecht University)
Proddutur, A., Rindner, D. J., Azouz, G., Beier, K. T., & Lür, G. (2026) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2026.102895
Ranjbari, M., Fakhri, S., Abbaszadeh, F., Kiani, A., Mohammadi-Noori, E., & Echeverría, J. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1748522 · Cited by 1
Ren, Y., Yan, G., Gao, J., Chu, W., Yang, X., Xie, J., Hui, P., Su, X., Ma, W., Hou, Y., et al. (2026) · Chinese Herbal Medicines · doi:10.1016/j.chmed.2026.03.005 · Cited by 2
Excitatory cholecystokinin neurons in CA3 area regulate the navigation learning and neuroplasticityPreprint
Huang, F., Baset, A., & Bello, S. T. (2026) · eLife · doi:10.7554/elife.109001.2
Behavioral and emotional abnormalities in mice with orthotopic colitis-associated colorectal cancer
Tan, Y., Zhang, R., Hao, H., Chen, Y., Kong, D., Wang, Y., & Wu, A. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116205
Potentialisation de la réponse antidépressive par la lumière : étude préclinique
Delcourte, S. (2019) · theses.fr (ABES) · doi:10.70675/7468b6d3zbf12z4888z88afzc63efcc91723
Implication of the laterodorsal tegmentum in adaptive and maladaptive stress responses
Broussot, L. (2020) · theses.fr (ABES) · doi:10.70675/39fe4c40z3f00z4570zb7b3ze438a205279c
The cholinergic system is involved in cervical dystonia – An [18F]FEOBV PET study
Lagerweij, S. A. J. E. A., Dalenberg, J. R., Smit, M., Centen, L. M., Coenen, M. A., van Egmond, M., de Vries, E. F. J., Peretti, D. E., & Tijssen, M. A. J. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107388
Abdulla, Z. I., Garcia-Milian, R., Giahyue, E., Fertuzinhos, S., Collin, F., Wang, W., Lam, T. T., Nairn, A. C., & Picciotto, M. R. (2026) · eNeuro · doi:10.1523/eneuro.0030-26.2026
Self-citationTumour innervation as a regulatory layer of cancer immunity
Wang, D., Fu, Z., Yang, Z., Liu, H., Li, Q., Zhu, D., & Li, W. (2026) · The Innovation Oncology · doi:10.59717/j.xinn-oncol.2026.100010
Wei, X., Zhong, X.-N., Ouyang, Y., Liu, Y., & Qin, W. (2026) · Journal of Physiology · doi:10.1113/jp290049
Khadrawy, Y. A., Mohammed, H. S., Hosny, E. N., Elkholy, N. S., & Ezz, H. S. A. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111753
Chaurasia, V., Modak, S. D., Singh, G. K., & Modi, G. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.05.017
Dharwadkar, J., Nayak, A. R., Rao, B. S. S., & Srikumar, B. N. (2026) · Annals of Neurosciences · doi:10.1177/09727531261448654
Molecular mechanisms of nicotinic acetylcholine receptors in mood dysregulation
Murthy, M. K., & Samal, D. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111880
Xu, Y., Du, J., Li, X., Diao, H., Nie, L., Yuan, C., Li, J., & Wang, Y. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03833-8
Zhu, H., Chen, Y., Song, X., Chen, Z., Zhang, J., Pu, X., Wang, J., & Rong, P. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106980
Li, J., Liu, G.-L., Wang, X.-T., Song, Z., Chen, H., Hou, H.-W., & Hu, Q.-Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1929468
Tan, J., Kong, Y., Feng, H., Yin, S., Yang, X., Sun, Z., Li, Z., Chen, L., & Huang, B. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.6c04296
Santos, S. A. A. R., Gois, R. R., Rodrigues, A. L. O. D. S., Batista, F. L. A., Vieira‐Neto, A. E., de Castro, T. C. F. C. R., Tavares, T. R. P., Leite, G. D. O., Frota, L. S., Barbosa, S. I. C. G., et al. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100878
Linde, J., Yildiz, C. B., Vöhringer, K., Nabbefeld, G., Graff, S., Pensold, D., Reichard, J., Hermanns, M., Koch, L., Müller, M. S., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-11079-x
Neuroendocrine and circuit remodeling under chronic social stress
So, Y. H., Shin, H. S., Lee, D. H., & Jung, E. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116534
Metadata
- Authors
- Mineur, Y. S., Obayemi, A., Wigestrand, M. B., Fote, G. M., Calarco, C. A., Li, A. M., & Picciotto, M. R.
- Affiliations
- Yale University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-02-11
- Volume
- 110
- Issue
- 9
- Pages
- 3573-3578
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3587265
- OpenAlex
- W2020386906
- Cited by
- 375
- References
- 46
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 21 · 2023: 24 · 2022: 38 · 2021: 34 · 2020: 38 · 2019: 30 · 2018: 33 · 2017: 20 · 2016: 24 · 2015: 27 · 2014: 18 · 2013: 15
- FWCI
- 13.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DA033945)
- National Institute of Mental Health (MH077681, R01MH077681)
- National Institute on Drug Abuse (P50DA033945, DA033945)
- National Institute of General Medical Sciences (T32GM007205)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- cholinergic neurotransmission, hippocampus, acetylcholinesterase, physostigmine, anxiety-like behavior, depression-like behavior, social defeat, fluoxetine, nicotinic acetylcholine receptors, muscarinic receptors, shRNA knockdown, mood disorders
- MeSH terms
- Acetylcholinesterase, Dependovirus, Animals, Antidepressive Agents, Anxiety, Behavior, Animal, Depression, Fluoxetine, Hippocampus, Humans, Male, Mice, Inbred C57BL, Phenotype, Physostigmine, Receptors, Cholinergic, Stress, Psychological, Time Factors, Signal Transduction, Cholinergic Antagonists, Hindlimb Suspension, RNA, Small Interfering, Mice, Resilience, Psychological, Gene Knockdown Techniques, Cholinergic Neurons
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review